About Nimble Therapeutics
Nimble Therapeutics is a company based in Madison (United States) founded in 2019 was acquired by AbbVie in December 2024. Nimble Therapeutics has raised $10 million across 1 funding round from investors including AbbVie and Telegraph Hill Partners. The company has 24 employees as of December 31, 2021. Nimble Therapeutics operates in a competitive market with competitors including Aqemia, NTxBio, Applied BioMath, Enveda and IMIDomics, among others.
- Headquarter Madison, United States
- Employees 24 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nimble Therapeutics, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nimble Therapeutics
Unlock access to complete
Funding Insights of Nimble Therapeutics
Nimble Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nimble Therapeutics
Nimble Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie and Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Locked | Locked | Locked |
Investor details for Nimble Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nimble Therapeutics
Investment portfolio details for Nimble Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nimble Therapeutics
Detailed financials for Nimble Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nimble Therapeutics Comparisons
Peer comparison for Nimble Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nimble Therapeutics
Nimble Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Applied BioMath, Enveda and IMIDomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| Locked | Locked | Locked |
Provider of AI-based platform to decipher the chemistry of nature and develop new medicines
|
|
| Locked | Locked | Locked |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
Detailed competitors of Nimble Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nimble Therapeutics
Complete news archive for Nimble Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nimble Therapeutics
Nimble Therapeutics was founded in 2019.
Nimble Therapeutics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Nimble Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Nimble Therapeutics is 24.
Nimble Therapeutics was founded in 2019 in Madison, United States, within the biotechnology sector. Drug discovery services centered on combinatorial chemistry are offered, with a focus on peptide technologies. A chemical synthesis platform has been developed to facilitate the creation and evaluation of various peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Operations emphasize efficient screening processes for potential therapeutic compounds in the pharmaceutical industry.
Nimble Therapeutics has 2 investors. Key investors include AbbVie, and Telegraph Hill Partners.